CONDUIT PHARMACEUTICALS INC(NASDAQ:CDT) stock News

CDT Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Conduit Pharmaceuticals

Conduit to Change Name to CDT Equity Inc.

a month ago - By: Conduit Pharmaceuticals

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

a month ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

a month ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

2 months ago - By: Benzinga - Mentions: MBRX NEOG CLRB NCNA ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Leadership Changes

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

3 months ago - By: Benzinga - Mentions: EVO RAPT ONCO ALTS ...

12 Health Care Stocks Moving In Friday's Intraday Session

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Leadership Changes

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

4 months ago - By: Conduit Pharmaceuticals

CONDUIT PHARMACEUTICALS INC (CDT) Stock News

CDT Latest News, Press Relases and Analysis

Conduit to Change Name to CDT Equity Inc.

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

12 Health Care Stocks Moving In Wednesday's Intraday Session

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

12 Health Care Stocks Moving In Friday's Intraday Session

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases